Sex-biased adaptive immune regulation in cancer development and therapyJohanna M. Schafer, Zihai Li, Qin Ma et al.|iScience|2022Cited by 30
Sex differences in bladder cancer: understanding biological and clinical implicationsPrakash Chaudhary, Xue Li, Biplab Singha et al.|Biology of Sex Differences|2025Cited by 17
Conditional Reprogramming Modeling of Bladder Cancer for Clinical TranslationDanyal Daneshdoust, Xuefeng Liu, Ming Yin et al.|Cells|2023Cited by 6
MP66-18 PREOPERATIVE FACTORS ASSOCIATED WITH REDUCED LENGTH OF STAY FOLLOWING ROBOTIC-ASSISTED RADICAL PROSTATECTOMY: WHO TO TREAT IN THE AMBULATORY SETTING?Grace Chen, Cheryl Lee, Lily Kaufman et al.|The Journal of Urology|2019Cited by 0
Conditional Reprogramming: A Living Biomarker and Phenotypic Screening Drug Platform for Urological CancerDanyal Daneshdoust, Xuefeng Liu, Nagireddy Putluri et al.|Unknown|2025Cited by 0